is all compounded semaglutide the same vs. Ozempic What is compounded semaglutide? Benefits,

doi: 10.1136/bmj.d7771

October 3, 2025

While the trial tested maintenance doses of 5, 10, and 15 mg (not 7.5 mg specifically as a maintenance dose), the dose-response curve suggests that 7.5 mg produces weight loss results roughly between the 5 mg and 10 mg groups

Mechanisms of Action-Mediated DDIs Furthermore, assessing DDIs for GLP-1 RAs and a dual GLP-1/GIP RA requires additional considerations, including the possible occurrence of DDIs mediated by mechanisms of action that remain poorly understood (Figure 3).120 Long-acting GLP-1 RAs remain in the body for an extended period (eg, with a mean residence time [MRT] of 224 hours at a steady state after administering 14 mg of oral semaglutide).141 This prolonged duration may be driven by albumin binding to the fatty acid residues of GLP-1 RAs and their ability to escape protease metabolism due to amino acid substitutions (Figure 1).141 They remain in the body, interacting with GLP-1 receptors in various organs, which could lead to DDIs through mechanisms of action such as slowing gastric emptying, reducing fat mass and inflammation, and increasing glomerular filtration rate (GFR) and renal plasma flow, consequently altering the pharmacokinetics of the victim drug (Figure 3).124,142 Investigations into mechanism of action-mediated pharmacokinetic DDIs are currently limited to those mediated by the slowing of gastric emptying, with examples summarized in other reviews.124,143 The pharmacokinetic DDI are commonly expressed in terms of victim drug and perpetrator drug

doi: 10.1002/jnr.23335 121 BellenguezCKkaliFJansenIEKleineidamLMoreno-GrauSAminNet al

However, the Institute for Clinical and Economic Review has reviewed the available data and concluded that oral Wegovy achieves an average weight loss difference of 11.4% compared to placebo, while the injectable version offers a 13.1% difference